Skip to content

Angioplasty and / or Stenting following Successful MechanicalThrombectomy for Intracranial Atherosclerosis-related Emergent Largevessel Occlusive Stroke:A multicenter, prospective, open-label, blindoutcome, randomized controlled trial

Angioplasty and / or Stenting following Successful MechanicalThrombectomy for Intracranial Atherosclerosis-related Emergent Largevessel Occlusive Stroke:A multicenter, prospective, open-label, blindoutcome, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079069
Enrollment
Unknown
Registered
2023-12-25
Start date
2023-12-29
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Interventions

Treatment group:Emerge angioplasty/or stenting combined with standard medical treatment

Sponsors

Jinan University First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years, gender not specified. (2) Onset to puncture time within 24 hours. This includes Wake-up stroke or patients without witnesses to the stroke; the time of symptom onset is defined as the "Last Known Well" (LKW) time. If onset to puncture is 1 but unrelated to neurological diseases (such as blindness, amputation, etc.). (5) Patient or their legal representative signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Severe organ (heart, lung, kidney, liver) failure. (2) Platelet count less than 40×10^9/L. (3) Currently using anticoagulants with a severe bleeding tendency (international normalized ratio >3) or active bleeding. (4) Severe uncontrolled hypertension. (5) Imaging shows intracranial hemorrhage, severe mass effect, tumors requiring surgical treatment, extracranial segment occlusion of the cervical internal carotid artery, simultaneous occlusion of multiple major arteries, moyamoya disease occlusion, or tandem occlusion. (6) Non-atherosclerotic stenosis, such as arteritis, vascular spasm, dissection, or NIHSS score =25 upon admission. (7) Pregnant women. (8) Participants involved in other studies conflicting with the current study. (9) Other situations where researchers believe it is inappropriate for individuals to participate in the study or may pose significant risks to patients (such as cognitive impairment preventing understanding and/or compliance with the study procedures and/or follow-up).

Design outcomes

Primary

MeasureTime frame
The incidence of ischemic stroke in the responsible vessel watershed within 90 ± 7 days after randomization;

Secondary

MeasureTime frame
Rate of responsible vessel re-occlusion within 7 ± 1 days after randomization;mRS 0-2 within 90 ± 7 days after random fraction;

Countries

China

Contacts

Public ContactHuang Li'an

Jinan University First Affiliated Hospital

huanglian1306@126.com+86 130 0519 9817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026